Therapeutic modulation of autophagy in cardiovascular disease Autophagy has emerged as one of the most actively investigated proteostasis pathways for therapeutic intervention in cardiovascular disease
These methodologies bolster the credibility of the observed associations between GLP-1 receptor agonist use and improved transplant outcomes
Diabetes Care 42(12):22622271 Funding This research was supported by the Industrial Strategic Technology Development Program (20018218, Development of oral drug formulation technology and process technology based on continuous process and RS-2023-00230559, Development of integrated solution technology for QbD-based continuous process) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea)
neoformans , a pathogen that induces very high rates of matricide
Pharmacological activation of amp-activated protein kinase ameliorates liver fibrosis in a metabolic dysfunction-associated steatohepatitis mouse model
Why Strength Training Matters on a GLP-1 Diet alone is not enough to protect lean mass during GLP-1 weight loss